Table 2 Sequential measures of blood pressures, heart rate, and monoximetria of patients according to prescribed drugs and the presence of hypertension, CAD, or AMI
Varenicline | ||
Presence of hypertension, CAD, or AMI | ||
Variables | No (n = 85) | Yes (n = 69) |
Initial SBP (mmHg) | 118 ± 14 | 131 ± 21 |
Second visit SBP (mmHg) | 117 ± 13 | 127 ± 20 |
Third visit SBP (mmHg) | 117 ± 15 | 128 ± 19 |
p value | 0.20 | 0.10 |
Initial DBP (mmHg) | 76 ± 10 | 81 ± 12 |
Second visit DBP (mmHg) | 74 ± 8 | 78 ± 10 |
Third visit DBP (mmHg) | 76 ± 10 | 79 ± 11 |
p value | 0.26 | 0.16 |
Initial HR (bpm) | 76 ± 11 | 76 ± 10 |
Second visit HR (bpm) | 75 ± 9 | 76 ± 10 |
Third visit HR (bpm) | 75 ± 8 | 74 ± 10 |
p value | 0.60 | 0.30 |
Initial monoximetria (ppm) | 15 ± 11 | 12 ± 7 |
Second visit monoximetria (ppm) | 8 ± 10 | 7 ± 6 |
Third visit monoximetria (ppm) | 4 ± 9 | 4 ± 5 |
p value | <0.001 | <0.001 |
Varenicline Plus Bupropione | ||
Presence of hypertension, CAD, or AMI | ||
Variables | No (n = 62) | Yes (n = 49) |
Initial SBP (mmHg) | 117 ± 14 | 128 ± 18 |
Second visit SBP (mmHg) | 117 ± 15 | 126 ± 21 |
Third visit SBP (mmHg) | 115 ± 15 | 129 ± 21 |
p value | 0.56 | 0.63 |
Initial DBP (mmHg) | 75 ± 8 | 81 ± 12 |
Second visit DBP (mmHg) | 74 ± 8 | 81 ± 12 |
Third visit DBP (mmHg) | 74 ± 8 | 81 ± 11 |
p value | 0.85 | 0.27 |
Initial HR (bpm) | 79 ± 10 | 73 ± 10 |
Second visit HR (bpm) | 74 ± 13 | 73 ± 10 |
Third visit HR (bpm) | 77 ± 10 | 73 ± 11 |
p value | 0.06 | 0.86 |
Initial monoximetria (ppm) | 17 ± 10 | 16 ± 8 |
Second visit monoximetria (ppm) | 11 ± 10 | 10 ± 7 |
Third visit monoximetria (ppm) | 7 ± 7 | 9 ± 8 |
p value | <0.001 | <0.001 |
Bupropione | ||
Presence of hypertension, CAD, or AMI | ||
Variables | No (n = 39) | Yes (n = 42) |
Initial SBP (mmHg) | 112 ± 14 | 132 ± 27 |
Second visit SBP (mmHg) | 117 ± 17 | 126 ± 23 |
Third visit SBP (mmHg) | 116 ± 15 | 132 ± 28 |
p value | 0.12 | 0.31 |
Initial DBP (mmHg) | 74 ± 7 | 81 ± 12 |
Second visit DBP (mmHg) | 76 ± 10 | 78 ± 10 |
Third visit DBP (mmHg) | 76 ± 9 | 82 ± 11 |
p value | 0.63 | 0.14 |
Initial HR (bpm) | 76 ± 10 | 73 ± 13 |
Second visit HR (bpm) | 76 ± 8 | 73 ± 14 |
Third visit HR (bpm) | 75 ± 9 | 74 ± 14 |
p value | 0.25 | 0.99 |
Initial monoximetria (ppm) | 14 ± 13 | 12 ± 11 |
Second visit monoximetria (ppm) | 7 ± 10 | 8 ± 6 |
Third visit monoximetria (ppm) | 6 ± 8 | 7 ± 6 |
p value | <0.001 | <0.001 |
Bupropione Plus NRT | ||
Presence of hypertension, CAD, or AMI | ||
Variables | No (n = 72) | Yes (n = 211) |
Initial SBP (mmHg) | 117 ± 16 | 132 ± 21 |
Second visit SBP (mmHg) | 117 ± 18 | 134 ± 22 |
Third visit SBP (mmHg) | 118 ± 18 | 132 ± 21 |
p value | 0.89 | 0.53 |
Initial DBP (mmHg) | 73 ± 10 | 80 ± 12 |
Second visit DBP (mmHg) | 73 ± 11 | 79 ± 13 |
Third visit DBP (mmHg) | 74 ± 11 | 80 ± 13 |
p value | 0.67 | 0.81 |
Initial HR (bpm) | 76 ± 11 | 73 ± 14 |
Second visit HR (bpm) | 75 ± 13 | 74 ± 12 |
Third visit HR (bpm) | 75 ± 11 | 74 ± 13 |
p value | 0.87 | 0.83 |
Initial monoximetria (ppm) | 11 ± 7 | 11 ± 8 |
Second visit monoximetria (ppm) | 7 ± 6 | 7 ± 8 |
Third visit monoximetria (ppm) | 5 ± 6 | 5 ± 5 |
p value | <0.001 | <0.001 |
NRT | ||
Presence of hypertension, CAD, or AMI | ||
Variables | No (n = 62) | Yes (n = 209) |
Initial SBP (mmHg) | 115 ± 17 | 130 ± 23 |
Second visit SBP (mmHg) | 119 ± 18 | 128 ± 23 |
Third visit SBP (mmHg) | 116 ± 17 | 130 ± 22 |
p value | 0.48 | 0.65 |
Initial DBP (mmHg) | 72 ± 11 | 78 ± 14 |
Second visit DBP (mmHg) | 74 ± 13 | 77 ± 13 |
Third visit DBP (mmHg) | 73 ± 13 | 77 ± 13 |
p value | 0.78 | 0.24 |
Initial HR (bpm) | 75 ± 11 | 72 ± 13 |
Second visit HR (bpm) | 74 ± 10 | 72 ± 14 |
Third visit HR (bpm) | 72 ± 10 | 72 ± 14 |
p value | 0.10 | 0.90 |
Initial monoximetria (ppm) | 10 ± 7 | 10 ± 6 |
Second visit monoximetria (ppm) | 6 ± 5 | 5 ± 5 |
Third visit monoximetria (ppm) | 4 ± 4 | 5 ± 5 |
p value | <0.001 | <0.001 |